Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2022-06-30 01:30LEADING REMOTE CARE MANAGEMENT PLATFORM, MEDSIEN RAISES $4.3 MILLION SEED ROUND TO HELP 150 MILLION AMERICANS GET BETTER CARE and more...
2022-06-29 01:30Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications and more...
2022-06-28 01:30CITRIS Invention Lab celebrates 10 years of innovation and more...
2022-06-27 01:30Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
2022-06-25 01:30Bristol Myers CAR-T therapy cleared by FDA for earlier lymphoma use and more...
2022-06-24 01:30Bringing biodiversity to the surface and more...
2022-06-23 01:30Protiviti Sees Positive Impact of Golf Brand Ambassador Program On and Off the Course and more...
2022-06-22 01:30Merck Announces that Chirfi Guindo will Lead Marketing for Merck Human Health and more...
2022-06-21 01:30Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma and more...
2022-06-18 01:30Teen Patient Joins BayCare in Advocating for Improved Access to Mental Health Services and more...
2022-06-17 01:30Bakar Fellows program names seven new Spark Award recipients and more...
2022-06-16 01:30Arcellx Announces Upsizing and Pricing of Follow-On Public Offering and more...
2022-06-15 01:30Vial Dermatology CRO adds Dr. Jonathan Zung to Scientific Advisory Board and more...
2022-06-14 01:30Innovent Announces the NMPA Acceptance of the New Drug Application for Tafolecimab Injection (anti-PCSK-9 antibody) and more...
2022-06-13 01:30IASO Bio and Innovent Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022 and more...
2022-06-12 01:30Previewing biopharma trends ahead of #BIO22; Looking back at #ASCO22; Smooth flight for bluebird?; and more 
2022-06-11 01:30Genentech campaign aims to increase cystic fibrosis awareness among Latino community and healthcare providers and more...
2022-06-10 01:30The Center for Social Dynamics to Offer 'Dreams Come TRUE', a Top-Tier Education Benefit for Employees through Workforce Edge and more...
2022-06-09 01:30Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022 and more...
2022-06-08 01:30Innovent Announces Phase 2 study of Mazdutide（IBI362） in Chinese Participants with Overweight or Obesity Met Primary and All Key Secondary Endpoints and more...
2022-06-07 01:30Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules and more...
2022-06-06 01:30Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and more...
2022-06-05 01:30#ASCO22: Gilead’s Trodelvy shows slim benefit in common form of breast cancer and more...
2022-06-04 01:30Fix California's Broken Public Mental Health Care and more...
2022-06-03 01:30Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination and more...
2022-06-02 01:30Vial to Launch Oncology CRO, Arati Rao, M.D. named as First Advisor and more...
2022-06-01 01:30Innovent Appoints Mr. Gary Zieziula as Independent Non-executive Director and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語